Nintedanib and pirfenidone. New antifibrotic treatments indicated for idiopathic pulmonary fibrosis offer hopes and raises questions.
作者信息
Raghu Ganesh, Selman Moisés
机构信息
1 University of Washington Medical Center Seattle, Washington.
出版信息
Am J Respir Crit Care Med. 2015 Feb 1;191(3):252-4. doi: 10.1164/rccm.201411-2044ED.
PMID:25635489
Abstract
摘要
Zotero 插件